Picture of Dottikon Es Holding AG logo

DESN Dottikon Es Holding AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-2.93%
3m-7.42%
6m-9.72%
1yr-4.77%
Volume Change (%)
10d/3m+33.94%
Price vs... (%)
52w High-11.3%
50d MA-2.7%
200d MA-3.08%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)32.52
PEG Ratio (f)4.72
EPS Growth (f)7.41%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.72
Price to Tang. Book3.73
Price to Free Cashflown/a
Price to Sales10.11
EV to EBITDA28.96

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.79%
Return on Equity9.55%
Operating Margin27.53%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueCH₣m174.77218.9251.93319.45326.27446.86447.717.17%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+102.92+58.7+3.66+46.59-8.11+25.54+0.24n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Dottikon Es Holding AG EPS forecast chart

Profile Summary

Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.

Directors

Last Annual
March 31st, 2024
Last Interim
March 31st, 2024
Incorporated
February 16th, 2005
Public Since
March 31st, 2005
No. of Employees
726
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ch flag iconSIX Swiss Exchange
Shares in Issue
13,774,204

DESN Share Price Performance

Upcoming Events for DESN

Half Year 2025 Dottikon Es Holding AG Earnings Release

Full Year 2025 Dottikon Es Holding AG Earnings Release

Similar to DESN

Picture of Cosmo Pharmaceuticals NV logo

Cosmo Pharmaceuticals NV

ch flag iconSIX Swiss Exchange

Picture of Curatis Holding AG logo

Curatis Holding AG

ch flag iconSIX Swiss Exchange

Picture of Galenica AG logo

Galenica AG

ch flag iconSIX Swiss Exchange

Picture of Novartis AG logo

Novartis AG

ch flag iconSIX Swiss Exchange

Picture of PolyPeptide AG logo

PolyPeptide AG

ch flag iconSIX Swiss Exchange

FAQ